LOGIN
Bisphosphonates do not reduce joint failure or THA in femoral head osteonecrosis patients
June 2016
Bisphosphonates do not reduce joint failure or THA in femoral head osteonecrosis patients
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A
The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials
Osteoporos Int. 2016 Jan;27(1):295-9Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
5 randomized controlled trials investigating the benefits of bisphosphonate therapy in the treatment of femoral head osteonecrosis were included in this meta-analysis. The purpose of this study was to determine whether bisphosphonate treatment should be recommended to patients suffering from this condition. The findings of this report indicated that bisphosphonates did not reduce the progression t...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.